Skip to content

Avanos Medical AVNS PM&R — Other segment items

Similar metrics at other companies

Mirion Technologies logo
MIRMedical Segment — Other segment items
$38.9M+4.0%
Viridian Therapeutics, Inc. logo
VRDNReportable Segment — Other items
-$11.29M-63.4%
Materion logo
MTRNPerformance Materials — Other segment items
$4.21M+39.9%
Sionna Therapeutics, Inc. Common Stock logo
SIONReportable Segment — Other segment items
$4.03M+916%
Ryan Specialty Holdings logo
RYANReporting Segment — Other segment items
$40.74M-12.7%
Clearwater Analytics logo
CWANReportable Segment — Other segment items
$12.84M+32.7%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept avns:OtherOperatingIncomeExpenseExcludingDepreciationAndAmortizationNet.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's pm&r — other segment items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's PM&R — other segment items?
Avanos Medical (AVNS) reported PM&R — other segment items of $0 in Q1 2026.
What does PM&R — other segment items mean?
Encompasses miscellaneous income or expense items specifically attributed to the Pain Management and Recovery segment that do not fit into standard operating categories. This metric helps investors identify non-recurring or unique operational impacts on the segment's financial performance.